03/16/2019
Dear Friends,
Feel free to "share" this post.
I can't hold back anymore. I need to tell you.
We've done it. We have engineered a stronger immune system for vertebrate mammals - almost certainly including the "human mammal".
We now have the technology to give a vertebrate mammal a better immune system.
We can also call it a "fundamentally enhanced immune system".
We are now in discussions with the FDA for both animal and human applications, and are getting close to human trials.
We have shown the treatment benefits mice with allergies.
We have also shown it benefits dogs with allergies.
This therapy gives a long-term upgrade to a mammal’s immune system.
We've given the treatment to dogs that have skin contact allergy, and it substantially lowered their reactivity to the allergens. We are now developing a veterinary clinic collaboration trial for dogs here in Vancouver.
Here is a published manuscript with experimental data and an explanation of the mechanism of action (“how it works”)… some suuuper light reading ;)
https://www.ncbi.nlm.nih.gov/pubmed/28679488
The above paper contains experimental results for:
- inflammatory colitis
- inflammatory breast cancer
- inflammatory egg allergy
The therapy is broadly applicable to allergic/inflammatory diseases.
We are leading with the development of applications to ALLERGY.
This is because we believe that the treatment of ALLERGY will be the fastest path to a very substantial market that has limited competition.
The technology, treatment and platform product were invented by Dr. Geoffrey W. Hoffmann and Dr. Reginald M. Gorczynski.
It was originally designed to prevent age-related, degenerative inflammatory diseases.
We have seen however, over the last 2 years that as a therapeutic "treatment" (not just a preventive) it also works to treat allergies, which involve a chronically "over-reactive" immune response.
It actually gets to the root cause of the problem.
It "calms down" an over-reactive immune system.
Based on the theory behind it, and on the data we've seen so far, we think it should be generally applicable to allergic diseases / hyper-sensitivities (that is, this will probably work to treat a wide range of both food, contact, and environmental allergies, including dust, grass and pollen allergies).
We are leading with the development of a platform allergy therapeutic, for our human clinical trials, because we believe that is the safest, fastest, and most cost-effective path forward.
Long-term, we see it as a general preventive treatment for a range of inflammatory diseases that should be integrated into public healthcare systems.
It has the very real potential to save our economies billions, by preventing a myriad of age-related inflammatory, degenerative diseases.
SO WHAT WE ARE LOOKING FOR?
1) DOGS WITH SEVERE ALLERGIES:
We will very soon be looking for participants in our upcoming dog allergy studies with a reputable allergy clinic here in Vancouver.
Do you or your friends have doggies that suffer from severe allergies? Kindly share this post, and have them reach out to me.
We will soon be initiating this veterinary study here in Vancouver.
The incentive is a no-charge, long-term solution to your dog's allergies.
Long-term, we will be looking for people with allergies to participate in our human clinical trials.
2) MEDIA CONTACTS AND INTERVIEWS
We are looking to tell the story of this discovery, as it will literally apply to the heath of all of us.
What would the world look like if we all had fundamentally stronger immune systems?
We want to share our story and vision with the world.
3) INVESTORS:
We are always looking for investors who share our vision and our values of health and well-being, and would like to own a portion of the company.
Let me know if you or a friend would like an investment information package.
The company (Network Immunology Inc.) owns strong intellectual property for the technology and product.
Kindly share this post with people that you think may be interested in the opportunity.
Thanks for any and all sharing.
Feel free to comment.
Thanks for reading!
All my best,
George
Co-founder and CEO
Network Immunology Inc.
Interact J Med Res. 2017 Jul 5;6(2):e8. doi: 10.2196/ijmr.7612.